Search results
Pfizer's Paxlovid fails as 15-day treatment for long COVID, study finds
FOX Business· 2 days agoA 15-day course of Pfizer's COVID-19 antiviral treatment Paxlovid did not relieve symptoms of long...
3 Stocks With Mouthwatering Dividends You Can Buy Right Now
Motley Fool via Yahoo Finance· 3 days agoHere's why they picked Gilead Sciences (NASDAQ: GILD), Organon (NYSE: OGN), and Pfizer (NYSE: PFE)....
Harlingen receives updated COVID-19 boosters, to begin administrating Friday
KRGV Rio Grande Valley· 6 days agoThe Harlingen Health Department has received 300 doses of the updated Pfizer booster shot and will...
Combined flu and Covid jab produces ‘higher immune response’ than separate injections
The Telegraph via Yahoo News· 15 hours agoAt the moment, Moderna’s Spikevax vaccine for Covid-19 is used in the NHS booster programmes,...
Pfizer's Paxlovid fails as 15-day treatment for long COVID, study finds
AOL· 4 days agoA 15-day course of Pfizer's COVID-19 antiviral treatment Paxlovid did not relieve symptoms of long COVID, according a study by Stanford University researchers. Currently, ...
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
Benzinga via AOL· 7 days agoOn Friday, Pfizer Inc (NYSE: PFE) revealed its drug for an advanced form of lung cancer showed...
When Donald Trump was asked about Taylor Swift, he commented on her appearance
Philly.com· 13 hours agoDonald Trump has thoughts on Taylor Swift — but they’re not about her sold-out international tour or...
COVID vaccine makers ready updated shots for fall immunization drive (NYSE:PFE)
Seeking Alpha· 6 days agoPfizer (PFE), BioNTech (BNTX), Moderna (MRNA) and Novavax (NVAX) reaffirm commitment to provide...
Want $1,000 in Dividend Income? Here's How Much You'd Have to Invest in Pfizer Stock. | The Motley...
The Motley Fool· 3 days agoGenerating dividend income can be an excellent way to put your cash to work. Pfizer pays a quarterly...
Updated Covid-19 Vaccine Targeting JN.1 Recommended By FDA Panel
Forbes· 6 days agoThe Vaccines and Related Biological Products Advisory Committee of the FDA evaluated the...